<DOC>
	<DOCNO>NCT00861016</DOCNO>
	<brief_summary>This open-label , non-comparative , multi-centre clinical study evaluate Efficacy safety Metoprolol Succinate prolonged-release tablet ( Betaloc Zok ) patient mild moderate essential hypertension .</brief_summary>
	<brief_title>Efficacy Safety Metoprolol Succinate Prolonged-Release Tablet Patients With Mild Moderate Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Felodipine</mesh_term>
	<criteria>Provision write informed consent Newly diagnose essential hypertension receive anti hypertensive treatment , patient without antihypertensive medication two week screen , 90mmHg &lt; SiDBP &lt; 110mmHg SiSBP &lt; 180mmHg . Known suspected secondary hypertension Resting HR &lt; 55bpm . Sick sinus syndrome Atrioventricular block first degree ( PR &gt; 0.24seconds ) , second third degree</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Post marketing study</keyword>
</DOC>